LOTEPREDNOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loteprednol, and what generic alternatives are available?
Loteprednol is a drug marketed by Hikma, Lupin, Sentiss, Sun Pharm, Amneal, Padagis Us, and Alembic. and is included in fourteen NDAs.
The generic ingredient in LOTEPREDNOL is loteprednol etabonate; tobramycin. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the loteprednol etabonate; tobramycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loteprednol
A generic version of LOTEPREDNOL was approved as loteprednol etabonate; tobramycin by ALEMBIC on December 10th, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LOTEPREDNOL?
- What are the global sales for LOTEPREDNOL?
- What is Average Wholesale Price for LOTEPREDNOL?
Summary for LOTEPREDNOL
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for LOTEPREDNOL |
| DailyMed Link: | LOTEPREDNOL at DailyMed |


